Advertisement
Advertisement
CLDX
Celldex Therapeutics, Inc
33.51
USDSponsored
-4.38
-11.56%
Sep 22, 15:59 UTC -4
Closed
Pre-Market
33.93
+0.42
+1.25%
Celldex Therapeutics, Inc Financial Snapshot
| Market Cap | 2.66B |
| Beta | 0.84 |
| Earnings Per Share (EPS) | -4.35 |
| Price-to-Book (P/B) Ratio | 4.20 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 0.17% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -52.35% |
| Current Ratio | 11.82% |
| Free Cash Flow | -127.82M |
